Details for New Drug Application (NDA): 065080
✉ Email this page to a colleague
NDA 065080 describes DISPERMOX, which is a drug marketed by Ranbaxy Labs Ltd and is included in two NDAs. Additional details are available on the DISPERMOX profile page.
The generic ingredient in DISPERMOX is amoxicillin. There are forty-six drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
The generic ingredient in DISPERMOX is amoxicillin. There are forty-six drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
Summary for 065080
| Tradename: | DISPERMOX |
| Applicant: | Ranbaxy Labs Ltd |
| Ingredient: | amoxicillin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 065080
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, FOR SUSPENSION;ORAL | Strength | 400MG | ||||
| Approval Date: | Aug 11, 2003 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, FOR SUSPENSION;ORAL | Strength | 200MG | ||||
| Approval Date: | Aug 11, 2003 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
